BIOQUAL, Inc.
BIOQ
$72.50
-$2.50-3.33%
| 11/30/2023 | 08/31/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 1.86% | -3.05% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.86% | -3.05% | |||
| Cost of Revenue | 6.20% | 12.77% | |||
| Gross Profit | -16.12% | -38.73% | |||
| SG&A Expenses | 6.32% | -69.05% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.21% | -15.88% | |||
| Operating Income | -51.82% | 209.79% | |||
| Income Before Tax | -46.13% | 219.22% | |||
| Income Tax Expenses | -46.18% | 200.83% | |||
| Earnings from Continuing Operations | -46.11% | 228.12% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -46.11% | 228.12% | |||
| EBIT | -51.82% | 209.79% | |||
| EBITDA | -33.37% | 517.49% | |||
| EPS Basic | -46.12% | 228.11% | |||
| Normalized Basic EPS | -46.13% | 219.22% | |||
| EPS Diluted | -46.31% | 227.30% | |||
| Normalized Diluted EPS | -46.13% | 219.22% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
